TWO SIGMA INVESTMENTS, LP

Position in ADCT — ADC Therapeutics SA

CIK 1179392 NEW YORK, NY

Position in ADCT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$827,552

-$1,677,530 QoQ

Shares Held

773,414

+15.8% QoQ

Ownership

0.606%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#15

of 113 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $775,744,366 across 48 Drug Manufacturers - Specialty & Generic names. ADCT ranks #33 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	2,076,260	$349,932,860
2	BCRX	Biocryst Pharmaceuticals Inc	6,775,349	$67,753,490
3	SUPN	Supernus Pharmaceuticals, Inc.	1,184,378	$55,085,420
4	ALKS	Alkermes plc.	1,038,311	$54,407,496
5	KNSA	Kiniksa Pharmaceuticals International, plc	561,480	$35,906,646
6	ZTS	Zoetis Inc.	386,428	$27,768,716
7	LQDA	Liquidia Corp	266,829	$21,274,276
8	IRWD	Ironwood Pharmaceuticals Inc	4,556,089	$19,181,134

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$827,552	773,414	+15.8%	Shares	Sole	2026-08-14
2026-03-31	$2,505,082	668,022	+459.2%	Shares	Sole	2026-05-15
2025-12-31	$421,697	119,461	+162.8%	Shares	Sole	2026-02-17
2025-09-30	$181,832	45,458	+1.7%	Shares	Sole	2025-11-14
2025-03-31	$63,007	44,686	-75.6%	Shares	Sole	2025-05-15
2024-12-31	$364,629	183,231	-25.3%	Shares	Sole	2025-02-14
2024-09-30	$772,546	245,253	-25.4%	Shares	Sole	2024-11-14
2024-06-30	$1,038,894	328,764	+498.7%	Shares	Sole	2024-08-14
2024-03-31	$246,559	54,913	-75.5%	Shares	Sole	2024-05-15
2023-03-31	$436,462	223,827	+307.7%	Shares	Sole	2023-05-15
2022-12-31	$210,800	54,896	+149.6%	Shares	Sole	2023-02-14
2020-12-31	$704,123	21,997	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.